Akums Drugs and Pharmaceuticals Bilanço Sağlığı
Finansal Sağlık kriter kontrolleri 5/6
Akums Drugs and Pharmaceuticals has a total shareholder equity of ₹7.2B and total debt of ₹5.7B, which brings its debt-to-equity ratio to 78.5%. Its total assets and total liabilities are ₹35.2B and ₹28.0B respectively. Akums Drugs and Pharmaceuticals's EBIT is ₹3.8B making its interest coverage ratio 9.7. It has cash and short-term investments of ₹2.8B.
Anahtar bilgiler
78.5%
Borç/özkaynak oranı
₹5.65b
Borç
| Faiz karşılama oranı | 9.7x |
| Nakit | ₹2.77b |
| Eşitlik | ₹7.20b |
| Toplam yükümlülükler | ₹27.96b |
| Toplam varlıklar | ₹35.16b |
Son finansal sağlık güncellemeleri
Güncelleme yok
Recent updates
Finansal Durum Analizi
Kısa Vadeli Yükümlülükler: AKUMS's short term assets (₹19.4B) exceed its short term liabilities (₹12.1B).
Uzun Vadeli Yükümlülükler: AKUMS's short term assets (₹19.4B) exceed its long term liabilities (₹15.9B).
Borç-Özkaynak Tarihçesi ve Analizi
Borç Seviyesi: AKUMS's net debt to equity ratio (40%) is considered satisfactory.
Borcun Azaltılması: Insufficient data to determine if AKUMS's debt to equity ratio has reduced over the past 5 years.
Borç Kapsamı: AKUMS's debt is well covered by operating cash flow (88.2%).
Faiz Kapsamı: AKUMS's interest payments on its debt are well covered by EBIT (9.7x coverage).